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Data on suppurative complications of otitis media in HIV-
infected children are scanty. A study conducted in rural 
KwaZulu-Natal1 identified otorrhoea as a marker for HIV 
screening in infants presenting at primary care clinics. As we 
noted large numbers of children with otorrhoea presenting 
to the Family Clinic for HIV at our hospital, we undertook a 
retrospective review. Our aim was to determine the disease 
burden of chronic suppurative otitis media and to relate it to 
disease progression and CD4 depletion.
Background
Tygerberg Academic Hospital is a tertiary facility in the 
Western Cape. The Family Clinic for HIV was established 
in January 1997. A nevirapine-based programme to reduce 
vertical transmission of HIV was established in our area in 
April 2003. Antiretroviral therapy (ART) became widely 
available in January 2004 through the provincial roll-out.
Patients and methods
A retrospective chart review was done of all HIV-infected 
children seen at the Family Clinic for HIV from 1 February 
1997 to 31 December 2001. In infants below 18 months of 
age, HIV infection was defined by 1 enzyme immunoassay 
(EIA) positive for antibodies to HIV-1, plus either P24 antigen 
detected with EIA, or HIV-specific RNA detected using the 
polymerase chain reaction (PCR).  In children older than 18 
months, 2 positive EIAs for HIV-specific antibodies confirmed 
infection.
We collected demographic and anthropometric data on 
all patients.  Children were staged according to the 1994 
Centers for Disease Control (CDC) clinical and immunological 
classification for HIV-infected children under the age of 13 
years.2 The clinical stage was noted at first presentation of 
otorrhoea. The CD4 T-cell percentage was recorded within a 
6-month window of otorrhoea. In patients without otorrhoea, 
the clinical stage at first presentation and CD4 T-cell percentage 
within the subsequent 6 months were noted.
Otorrhoea was classified as mild (a single episode lasting 
less than 1 month) and severe (either a single episode lasting 
more than 1 month or more than 1 episode). The classification 
was modified from that proposed by Sabella.3
Weight-for-age z-scores (WAZs), odds ratios (ORs) and 95% 
confidence intervals (CIs) were calculated using EpiInfo 2000 
(CDC, Atlanta, Ga., USA). Data were analysed using JMP 
version 4.04 and EpiInfo 2000. Continuous data are presented 
as medians and interquartile ranges (IQR) and were compared 
using the Wilcoxon’s rank test. Categorical data were compared 
using chi-squares. Logistical regression was performed using 
SAS version 9.1.3 and SAS Enterprise Guide 3.0.2. Approval to 
conduct this review was obtained from the institutional review 
board of Stellenbosch University. 
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Background. Chronic otorrhoea occurs commonly in HIV-
infected children. However, there are few data on incidence 
and severity.
Objective. To document the prevalence of otorrhoea in the clinic 
attendees.
Methods. A retrospective chart review was done of all HIV-
I infected children seen at the Family Clinic for HIV from 
1 February 1997 to 31 December 2001, a period preceding 
widespread availability of antiretrovirals. Otorrhoea was 
classified into two groups, viz. group 1 (mild): an episode 
lasting less than 1 month, and group 2 (severe): an episode 
lasting more than 1 month or more than 1 episode of otorrhoea. 
The clinical and immune stages of the children were noted.
Results. Of 326 children seen during the study period, 104 
(32%) had otorrhoea. Forty-five (13.8%) had mild and 59 
(18.1%) severe otorrhoea. Two hundred and eighty-eight 
(88.6%) had either Centers for Disease Control stage B or C 
disease. The median CD4 percentage in children with otorrhoea 
was 17.5% (8.3 - 23%) versus 21% (14 - 28%) in those without 
otorrhoea (p=0.004). The odds ratio (OR) of children in stage B 
or C not having severe otorrhoea was 0.1 (0.01 - 0.72, p = 0.013). 
The OR for immune class 2 or 3 without severe otorrhoea was 
0.39 (0.18 - 0.85, p = 0.021).
Conclusions. Otorrhoea contributes to the morbidity of HIV 
infection in children.  It is a marker for symptomatic disease 
and CD4 depletion and should be included in clinical 
classifications.
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Results
Demographic and anthropometric data are shown in Table I.  
Of the 326 children seen at the clinic during the study period, 
104 (32%) had otorrhoea. There was equal gender distribution. 
The median age at which otorrhoea was first diagnosed was 
21 months (IQR 13.4 - 40.4 months). Most of the children with 
otorrhoea had symptoms on first presentation to the clinic. 
Two hundred and twenty-eight children were staged to either 
CDC clinical class B or C. Only 15 children received ART drugs 
during this time, all of whom were in stage C. CD4 percentages 
were measured in 245 children. The median CD4 percentage in 
children with otorrhoea was 17.5% (8.3 - 23%) versus 21% (14 - 
28%) in those without otorrhoea (p=0.004).
Severity of otorrhoea is shown in Table II. Forty-five (13.8%) 
of the study population had mild and 59 (18.1%) had severe 
otorrhoea. Declining CD4% was related to severity of otorrhoea 
(p=0.028). 
In a multivariate logistical regression model, only CD4 
depletion was significantly associated with ‘all’ otorrhoea 
(Wald chi-squares 6.4, p = 0.011). Low WAZ approached 
significance (p = 0.07) and stage of disease approached 
significance for the absence of otorrhoea. For severe otorrhoea, 
no factors were significant.  As the model did not fit well 
(R2=0.066 for presence or absence of otorrhoea and R2=0.087 
for severe versus no otorrhoea), we combined clinical stages 
B and C for comparison with N and A (moderate or severe 
versus symptomatic or mild) and immunological stages 2 and 
3 for comparison with stage 1 (any immunosuppression versus 
none) and calculated the ORs. The ORs for otorrhoea in mild 
or asymptomatic HIV or in the absence of CD4 depletion were 
significantly reduced, more so for severe otorrhoea. Data are 
shown in Table III. The OR for absence of severe otorrhoea was 
0.1 (95% CI: 0.01 - 0.72, p = 0.013) when stage A was compared 
with stages B and C. 
Discussion
We have documented that otorrhoea has a high prevalence rate 
in HIV-infected children without access to ART. It occurs more 
commonly in symptomatic than asymptomatic children and 
is a marker for moderate to severe CD4 T-cell depletion. The 
association with stage B and C disease suggests that otorrhoea 
might be included in a staging system for HIV-infected 
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Table I. Demographic data on children attending the Family Clinic for HIV at Tygerberg Children’s Hospital,   
February 1997 - December 2001
    Total  Without otorrhoea (N) With otorrhoea (N)  p-value
Total    326  222 (68%)   104 (32%) 
Male/female ratio     103:115   55:51   0.19
Age* (mo.) (median)    16.7 (IQR 7.4 - 45.4)  19.4 (IQR 10.6 - 35.7) 0.93
Weight-for-age z-score (median)   –1.83 (IQR –2.7 - –0.7) –2.16 (IQR –3.2 - –0.9)  0.24
CDC classification
  N    5 (2%)  5 (3%)   0   0.14
  A    33 (10%)  27 (12%)   6 (5%)
  B    172  (53%) 112 (50)   60 (57%)
  C    116 (36%)  78 (35%)   38 (37%)
CD4%†  (median)     21 (IQR 14 - 28)  17.5 (IQR 8.25 - 23)  0.004
*Age in months at first episode of otorrhoea, or age at first visit without otorrhoea.
†CD4 percentages measured in 245 children.    
Table II. Severity of otorrhoea and the Centers for Disease Control (CDC) clinical and immunological classification of HIV-
infected children (N (%))
     Severe otorrhoea*     
  Mild otorrhoea  (>4 wks duration and/
  (<4 wks duration)  or >1 episode)  Otorrhoea absent  p-value
Clinical  N=45 (13.8%)  N=59 (18.1%)  N=222 (68%)   
classification       
  N  0   0   5 (2%)   0.054
  A  5 (11%)   1 (2%)   27 (12%)
  B  27 (60%)   33 (56%)   112 (50%)
  C  13 (29%)   25 (42%)   78 (35%) 
CD4%†  
(median)  21% (IQR 14 - 27%)  18% (IQR 8 - 30%)  16% (IQR 7 - 22%)  0.028
*Severe otorrhoea >4 weeks – 21 and >1 episode – 38.
†CD4 percentages measured in 245 children.
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children. The association with at least moderate CD4 depletion 
suggests that it may be an especially useful marker where 
lymphocyte subsets cannot be measured.
To the best of our knowledge, this study is one of only two 
comprehensive surveys done on otorrhoea in HIV-infected 
children. In other studies, otorrhoea was noted but neither 
incidence data nor relationship with severity of HIV disease 
in children were explored. Otorrhoea occurred in 14 (19.4%) of 
72 children from Great Ormond Street Hospital in the UK.4 All 
children showed at least moderate immunosuppression. In a 
study from KwaZulu-Natal evaluating markers for HIV testing 
in primary care clinics, the odds of a child with otorrhoea being 
HIV-infected were 3.2.1 Lastly, in a survey of 391 Ethiopian 
children with chronic suppurative otorrhoea, HIV infection 
was reported to occur commonly.5
In a review of otitis media in developing countries, Berman 
noted that the prevalence of otorrhoea varied between 0.6% 
and 4.4% of children attending schools.6 In a recent survey 
of children aged 2 - 5 years in South India, the prevalence 
was 5.7%.7 The associated hearing loss causes significant 
morbidity.5,7
As this was a retrospective study, we were unable to 
comment on response to antiretroviral therapy or document 
causative organisms. Schaaf et al. had previously cultured 
Mycobacterium tuberculosis from children with chronic 
otorrhoea.8 Also we could not comment on morbidity or 
management of otorrhoea.
Conclusions
Severe otorrhoea should be included as a criterion for moderate 
to severe disease and as a marker for CD4 depletion. Otorrhoea 
is a significant burden in HIV-infected children. Otitis media 
should be managed aggressively to prevent suppurative 
complications. 
Paediatric staff attending to children with HIV infection 
should be familiar with management of ontological 
complications of the disease and otorrhoea. Hearing should 
be assessed in all these cases, as hearing loss will impact 
significantly on the language development and school 
performance of these children.
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Table III. Odds ratios for severity of otorrhoea and severity of HIV disease
       Odds ratio
    Disease classification (OR)  95% CI                p-value*
Otorrhoea
Severe    N + A v. B + C  0.10  0.01 - 0.72   0.01
    B v. C   0.92  0.49 - 1.74   0.90
All    N + A v. B + C  0.36  0.13 - 0.95   0.037
    B v. C   1.1  0.65 - 1.87   0.80
Immunological classification
Severe    I v. II + III  0.39  0.17 -  0.88  0.02
    I v. II   0.39  0.15 - 0.98   0.04
    II v. III   0.98  0.44 - 2.18   0.89
All    I v. II + III  0.64  0.34 - 1.19   0.17
    I v. II   0.70  0.34 - 1.45   0.39
    II v. III   0.82  0.40 - 1.68   0.69
*Yates’s corrected chi-square test.
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